Anti‐inflammatory effects of the novel inhaled phosphodiesterase type 4 inhibitor CHF 6001 on virus‐inducible cytokines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti‐inflammatory effects of the novel inhaled phosphodiesterase type 4 inhibitor CHF 6001 on virus‐inducible cytokines

Published:2016-01-15 Issue:1 Volume:4 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Edwards Michael R.¹²,Facchinetti Fabrizio³,Civelli Maurizio³,Villetti Gino³,Johnston Sebastian L.¹²

Affiliation:

1. Airway Disease Infection Section National Heart Lung Institute Imperial College London London United Kingdom

2. MRC and Asthma UK Centre for Allergic Mechanisms of Asthma London United Kingdom

3. Corporate Pre‐clinical R&D Chiesi Farmaceutici S.p.A. Parma Italy

Funder

Chiesi Farmaceutici

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.202

Reference63 articles.

1. Novel Class of Benzoic Acid Ester Derivatives as Potent PDE4 Inhibitors for Inhaled Administration in the Treatment of Respiratory Diseases

2. Defining critical roles for NF‐κB p65 and type I interferon in innate immunity to rhinovirus

3. A Major Functional Role for Phosphodiesterase 4D5 in Human Airway Smooth Muscle Cells

4. Budesonide/Formoterol Maintenance Plus Reliever Therapy

5. Association between human rhinovirus C and severity of acute asthma in children

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sputum Cytokine Profiling in COPD: Comparison Between Stable Disease and Exacerbation;International Journal of Chronic Obstructive Pulmonary Disease;2022-08

2. The PDE4 inhibitor tanimilast shows distinct immunomodulatory properties associated with a type 2 endotype and CD141 upregulation;Journal of Translational Medicine;2022-05-10

3. The PDE4 Inhibitor Tanimilast Restrains the Tissue-Damaging Properties of Human Neutrophils;International Journal of Molecular Sciences;2022-04-29

4. The PDE4 Inhibitor Tanimilast Blunts Proinflammatory Dendritic Cell Activation by SARS-CoV-2 ssRNAs;Frontiers in Immunology;2022-01-24

5. Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease;Frontiers in Pharmacology;2021-11-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3